Oxigen-Ozonetherapy Treatment Combined with Gonadotropin-Releasing Hormone Agonist in Endometriosis and IVF: Successful Pregnancy in a Case Series - Abstract
Nowadays, oxygen-ozonetherapy is used in many chronic inflammatory diseases, especially in orthopedics, neurology, and infectious diseases. Recent
studies have confirmed that oxygen-ozonetherapy could be used in urology and gynecology to treat inflammatory conditions and infections. We intend to
understand if oxigen-ozone systemic therapy applied to In Vitro Fertilization (IVF) could improve pregnancy outcomes. We present three cases of long-term
primary infertility with previous implantation failures suffering from endometriosis or adenomyosis. Before the embryo-transfer, the patients were treated with
a 2/3-month course of Gonadotropin-Releasing Hormone Agonist (GnRHa) combined with 3-4 sessions of oxygen-ozone systemic therapy. We combined a
mixture of oxygen and ozone, with ozone concentrations ranging from 30µg to 45µg, increasing the dosage at each session. The oxygen-ozonetherapy session
started during the hormonal endometrial preparation and stopped 1-7 days before the embryo-transfer. All the patients were also treated with intravenous
vitamins. In all our patients, we obtained a positive blood ?- Human Chorionic Gonadotropin (hCG) test and an ongoing pregnancy